Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-538.39%
↑ 97% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-21291.10%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -538.39% | -95.0% |
| 2024 | -276.11% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | +100.0% |
| 2018 | -169514.29% | - |